PERSPECTA

News from every angle

Back to headlines

KalVista Pharmaceuticals Exceeds Q4 Topline Estimates

KalVista Pharmaceuticals announced financial results for its fourth quarter, reporting figures that surpassed topline estimates.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.